Prio - June 18, 2019
Pharma industry confronts growing problem of pharmaceutical waste
Pharmaceuticals in the environment is a growing problem of global concern. Drugs taken by humans and animals find their way into rivers, lakes and even drinking water and can have devastating effects on both aquatic and human health.
Prio - March 1, 2019
Mini-Interview: Miguel Forte, CEO of Zelluna
Zelluna, a biopharmaceutical company founded in 2016, focuses on the development of T-Cell Receptor (TCR) based immunotherapies. The company has several TCRs in different stages of development. “We are developing cell therapies for solid tumors by genetically engineering the surface receptors of patient lymphocytes. We are also targeting cancer via the immune system, utilizing lymphocytes,” […]
Collaboration - September 19, 2018
Tampere – A perfect location for R&D and Innovation
Located between two lakes, Näsijärvi and Pyhäjärvi, Finland’s Manchester possesses a vibrant ecosystem, supporting life science collaborations across disciplines. In a beautiful Finnish landscape consisting of lakes and nature reserves, and with characteristic red brick buildings revealing the industrial history, lies Finland’s second largest city region with close to half a million inhabitants. The city […]
Prio - May 15, 2018
Oslo – Making its mark in cancer studies and multidisciplinary research
For centuries, Oslo has been Norway’s undisputed center of government, industry and culture, and now it is becoming one of the nation’s and region’s major life science hubs. Home to a top university and hospital, as well as a major cancer research coalition, the city is making its mark in cancer studies and multidisciplinary research. Life […]
Prio - March 27, 2018
Life Science Billion Makers
Ironically, there is less serendipity in the success Saeid Esmaeilzadeh and Ashkan Pouya have achieved as business-makers than there is traditional hard work.
Prio - March 27, 2018
Building a life science business – Balancing risk and vision
Tanja Dowe, Head of Debiopharm Innovation Fund, gives us her insights from the hard but exciting work of building a life science business and what it takes to make it in an ever rapidly changing industry.